Informație de încredere. Sprijin real.

NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Articole și ghiduri recomandate

StudiuADHDÎncredere bună28.06.2026

Three-Year Outcomes of Motivational Interviewing-Enhanced Cognitive-Behavioral Therapy for Adolescent ADHD: A Randomized Community Trial

This randomized controlled trial evaluated long-term effects of STAND (cognitive-behavioral therapy combined with motivational interviewing) versus usual care for adolescents with ADHD across community clinics over 3 years. Licensed therapists delivering STAND showed superior outcomes in hyperactivity/impulsivity, parent-teen conflict, and organizational/time management skills compared to unlicensed providers, though intent-to-treat analyses showed no overall group differences.

StudiuAutism + ADHDÎncredere înaltă27.06.2026

Validation of the German Parent-Report Anxiety Scale for Autistic Children: Addressing Diagnostic Overlap and Autism-Specific Anxiety Patterns

This validation study examined the German version of the Anxiety Scale for Children with Autism Spectrum Disorder-Parent Version (ASC-ASD-P) in 317 youth at an autism clinic, including 120 autistic children, demonstrating excellent internal consistency and convergent validity with established behavioral measures. Autistic youth showed higher anxiety and uncertainty scores than non-autistic peers, confirming the scale's sensitivity to autism-specific anxiety presentations, though some subscales require refinement for broader applicability across the autism spectrum.

StudiuAutism + ADHDÎncredere înaltă26.06.2026

Agomelatine versus escitalopram for depression in people with epilepsy: A randomized controlled trial

This double-blind randomized trial compared agomelatine and escitalopram in 51 people with epilepsy and major depressive disorder, evaluating effects on depression, seizure frequency, sleep, cognition, and quality of life. Both medications improved depression similarly with minimal adverse events; escitalopram showed greater quality-of-life improvement while agomelatine showed better verbal memory outcomes, with no significant effects on seizure frequency in either group.

StudiuADHDÎncredere înaltă26.06.2026

Central sensitization symptoms in children with ADHD and their parents: a case-control study

This case-control study found that children with ADHD reported significantly higher central sensitization (heightened pain and sensory sensitivity) symptoms compared to neurotypical peers, with stronger correlations between central sensitization scores and pain intensity in the ADHD group. Parents of children with ADHD also showed elevated central sensitization symptoms, suggesting potential familial patterns in the co-occurrence of ADHD and central sensitization.

StudiuADHDÎncredere bună26.06.2026

ADHD Diagnosis in Children Using EEG Amplitude Modulation Features and Machine Learning

This study proposes a diagnostic framework for childhood ADHD by extracting amplitude modulation features from EEG signals decomposed via wavelet analysis, achieving 99.46% accuracy with a KNN classifier. The approach integrates conventional and novel AM features, with discriminative information concentrated in gamma/beta bands and frontal brain regions, outperforming previous methods.